Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
A London-based company, Novel Cardiovascular Systems Inc, has developed a unique multifunction system for measuring endothelial (arterial wall) cell remodelling under different types of laminar, turbulent and intermittent pulsatile flows that are associated with the onset and development of heart disease, notably atherosclerosis (narrowing of the artery). In order to accelerate the product to market, NCSI must validate the system with respect to cell biology and blood flow mechanics. Specifically, cell viability and the accuracy of hemodynamic (blood flow) measurements in an in vitro flow channel must be quantified. The proposed research will examine endothelial cell response under a range of realistic and quantified pulsatile flow conditions, thereby providing invaluable contributions to the literature. More importantly, for NCSI, it is critical to realize the project to accomplish a fully validated system in order to accelerate timeto- market. In addition, the project will further expand the capabilities of current flow system.
Eric Savory
Novel Cardiovascular Systems Inc
Engineering
Health and Related Sciences & Technology
Western University
Elevate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.